Tissue Engineered 3D Constructs for Volumetric Muscle Loss

• Published in: Annals of biomedical engineering Vol. 52; no. 9; pp. 2325 - 2347
• Main Authors: Gahlawat, Sonal, Oruc, Doga, Paul, Nikhil, Ragheb, Mark, Patel, Swati, Fasasi, Oyinkansola, Sharma, Peeyush, Shreiber, David I., Freeman, Joseph W.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.09.2024; Springer Nature B.V
• Subjects: Animals; Biochemistry; Biological and Medical Physics; Biomaterials; Biomedical and Life Sciences; Biomedical Engineering and Bioengineering; Biomedical materials; Biomedicine; Biophysics; Classical Mechanics; Damage; Design factors; Growth factors; Humans; Injury prevention; Innervation; Muscle, Skeletal; Muscles; Musculoskeletal system; Recovery of function; Regeneration; Review; Scaffolds; Skeletal muscle; Tissue engineering; Tissue Engineering - methods; Tissue Scaffolds; Vascularization; Hydrogels; Tissue engineering; Decellularization; Skeletal muscle regeneration; Electrospinning; Volumetric muscle loss; Scaffolds; Biomaterials
• ISSN: 0090-6964; 1573-9686; 1573-9686
• DOI: 10.1007/s10439-024-03541-w

Severe injuries to skeletal muscles, including cases of volumetric muscle loss (VML), are linked to substantial tissue damage, resulting in functional impairment and lasting disability. While skeletal muscle can regenerate following minor damage, extensive tissue loss in VML disrupts the natural regenerative capacity of the affected muscle tissue. Existing clinical approaches for VML, such as soft-tissue reconstruction and advanced bracing methods, need to be revised to restore tissue function and are associated with limitations in tissue availability and donor-site complications. Advancements in tissue engineering (TE), particularly in scaffold design and the delivery of cells and growth factors, show promising potential for regenerating damaged skeletal muscle tissue and restoring function. This article provides a brief overview of the pathophysiology of VML and critiques the shortcomings of current treatments. The subsequent section focuses on the criteria for designing TE scaffolds, offering insights into various natural and synthetic biomaterials and cell types for effectively regenerating skeletal muscle. We also review multiple TE strategies involving both acellular and cellular scaffolds to encourage the development and maturation of muscle tissue and facilitate integration, vascularization, and innervation. Finally, the article explores technical challenges hindering successful translation into clinical applications.